| abstract |
The invention relates to an externally active immunostimulating pharmaceutical composition characterized in that it contains a diester having the general formula (I) wherein R is CH3, X is L-Ala or L-Thr, R1 is a hydrocarbonaceous group having from 1 to 4 carbon atoms, R2 is a hydrocarbonaceous group having 1 or 2 carbon atoms, in an externally administered formulation compatible with an administration of active principle comprised between 0.1 mg and 5 mg par kg of weight to human beings or animals. |